LYTIR

Company · PTIX

Protagenic Therapeutics, Inc.\new

PTIX is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 7 occasions ($31K); 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $31K in total; Insider sales: $0 in total.Jul: Insider purchases $5KAug: Insider purchases $26KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $31KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Garo H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought on 7 days latest Aug 21, 2026 bought $31K
Every trade (7)
  1. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 21, 2026 20,000 shares filing $13K
  2. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 20, 2026 16,634 shares filing $10K
  3. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 19, 2026 2,700 shares filing $945
  4. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 11, 2026 2,220 shares filing $710
  5. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 6, 2026 685 shares filing $151
  6. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF bought Aug 5, 2026 5,000 shares filing $1K
  7. BUYGaro H. Armen, EXEC. CHAIR & PRINCIPAL OFF. bought Jul 30, 2026 26,291 shares filing $5K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Creation of a direct financial obligation filing Nov 6, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.